OPMI LUMERA 700 from Carl Zeiss Meditec Receives Design Award

JENA, 03.05.2010. – A red dot award for high design quality now also adorns the OPMI® LUMERA 700 surgical microscope. The 30-member international jury has honored both the excellent conception and outstanding design of this leading edge surgical microscope for ophthalmology.

In addition to the assessment criteria of innovativeness, functionality and quality, the OPMI LUMERA 700 was able to score with the red dot jury due to its ease of use and longevity. The jury confirmed the opinion of surgeons and doctors from everyday practice: the technology of Stereo Coaxial Illumination (SCI) is innovative and, with its outstanding image quality and stable, bright red reflex, provides cataract surgeons with effective support in their work. The functionality of the RESIGHT fundus viewing system, which displays the back of the eye with superb clarity and detail in retinal surgery, was also highlighted by the jury. In addition to the legendary optical quality associated with the ZEISS brand, the integration of functions enables not only excellent ergonomics and stress-free surgery for the ophthalmologist, but also optimal outcomes for the patient. The integrated keratosope permits visualization of the corneal curvature during the surgery. In addition, OPMI LUMERA 700 adapts automatically to the field of surgery: when the RESIGHT 700 fundus viewing system is moved into position, the Invertertube E and the MediLive Trio Eye video camera immediately switch to the retinal mode. The result for the surgeon: an upright, bright microscope and video image. To support the surgical team, OPMI LUMERA 700 also features an assistant’s microscope and a video camera in HD or SD quality.

Image: OPMI LUMERA 700

OPMI LUMERA 700 outshone competitors’ systems in the contest not least because of its ease of use and user-friendliness. Intuitive and straightforward operation is possible via the touchscreen. By enclosing all potentially obstructive or interfering factors such as cables, the housing is an optimally self-contained unit. This means that the eye of the user is immediately directed to the key controls for the innovative assistance functions and the cleaning process is considerably simplifed. The foot control panel is also operated without cables. To ensure further workflow streamlining in the future, OPMI LUMERA 700 is already equipped for exchanging information with other systems used by the ophthalmologist.

“All products that received the red dot design award had to convince a jury of international experts. These products stand out through their excellent designs and innovativeness and were able to successfully demonstrate their quality in one of the toughest design contests in the world,” says design expert Professor Dr. Peter Zec, the initiator of the red dot design award. Overall, designers and companies from 57 nations took part with a total of 4,252 products in the product design category of this year’s red dot award.

The award ceremony will take place in the Essen Aalto Theater in Germany on July 5, 2010. In Essen, the European Capital of Culture in 2010, OPMI LUMERA 700 will then be presented in a special four-week exhibition in the red dot design museum in the Zollverein coal mine industrial complex.

Eva Sesselmann
Director Corporate Communications
Carl Zeiss Meditec AG
Phone: +49 3641 220-331
Fax: +49 3641 220-112
E-Mail: press@meditec.zeiss.com

Patrick Kofler
Director Investor Relations
Phone: +49 3641 220-106
Fax: +49 3641 220-117
E-Mail: investors@meditec.zeiss.com

Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies.

The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases – including implants and consumable materials.

The company creates innovative visualisation solutions in the field of microsurgery. Carl Zeiss Meditec’s medical technology portfolio is rounded off by promising future technologies such as intraoperative radiation therapy.

In the financial year 2008/2009 (30 September) the 2,100 employees generated revenue of approximately EUR 640 million. The head office of Carl Zeiss Meditec is in Jena, Germany. The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France.

35 percent of Carl Zeiss Meditec shares are in free float. The remaining 65 percent are held by Carl Zeiss AG, one of the world’s leading groups engaged in the optical and opto-electronics industry. Carl Zeiss offers innovative solutions for the future-oriented markets of “Medical and Research Solutions”, “Industrial Solutions” and “Lifestyle Products”. The head office of Carl Zeiss AG is in Oberkochen, Germany. In financial year 2008/09 (balance sheet date 30 September) the group posted sales of around € 2.1 billion. The Carl Zeiss Group has approximately 13,000 employees, including more than 8,000 in Germany.

Further information:

www.meditec.zeiss.com